Labshake search
Citations for R&D Systems :
3601 - 3650 of 4197 citations for B7 1 CD80 Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2024Quote: The following antibodies were used: goat anti-PDGFR alpha 1: 200 (R&D Systems, AF1062), mouseanti-EZRIN 1:1000 (Sigma-Aldrich ...
-
bioRxiv - Microbiology 2024Quote: Viral titers were determined using the HIV-1 Gag p24 DuoSet ELISA (R&D Systems). After seeding TZM-bl cells at 1 × 104 in flat-bottom 96-well plates (CELLTREAT) ...
-
bioRxiv - Immunology 2023Quote: ... goat polyclonal anti-MMR/CD206 (1:250, R&D systems, cat. no. AF2535, RRID: AB_2063012), rabbit polyclonal anti-Tyrosine hydroxylase (1:400 ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by 4 hour incubation with mouse anti-O4 IgM (1:1000; R&D Systems) and rat anti-MBP (1:500 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and treated with recombinant Sonic Hedgehog 1 μg/ml (1845, R&D Systems, Minneapolis, MN) or vehicle control for 24 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... anti-s100a8 rat IgG2B monoclonal (R&D Systems; clone # 335806; Cat: MAB3059-SP 1:200) and anti-NFH chicken polyclonal (Novus Biological ...
-
bioRxiv - Molecular Biology 2023Quote: ... sections were analyzed using rabbit polyclonal antibodies against CD31 (AF3628-R&D Systems, 1:30) and α-smooth muscle actin (α-SMA ...
-
bioRxiv - Immunology 2023Quote: ... and were partially pre-stimulated with neutralizing IL1R1 antibody (1:100, R&D Systems, USA) for 1h ...
-
bioRxiv - Immunology 2023Quote: ... cells were partially pre-stimulated with neutralizing IL1R1 antibody (1:100, R&D Systems, USA) for 1h ...
-
bioRxiv - Physiology 2023Quote: ... primary antibodies of 1:200 Goat anti-CD31 (R&D systems, U.K, goat anti-PECAM1) and 1:500 anti-desmin (Abcam ...
-
bioRxiv - Developmental Biology 2023Quote: ... Chordin like-1 recombinant protein 0.4 μg/mL (R&D Systems 1808-NR-050/CF). For 2-DOG wash-out experiments ...
-
bioRxiv - Microbiology 2023Quote: ... and LYVE-1 conjugated to A647 (clone 223322 R&D systems, used at 20 μg). A temporary glass window (Merk rectangular coverglass ...
-
bioRxiv - Cell Biology 2023Quote: ... Recombinant mouse Follistatin-like 1 protein (rFSTL1, R&D systems, MN, #1738-FN, 100ng/ml) was added into the culture media 24 h after plating cells and incubated for 24 hrs ...
-
bioRxiv - Neuroscience 2023Quote: ... by using a cocktail of antibodies: goat anti-podocalyxin (1:1500, AF1556, R&D Systems), goat anti-CD31 (1:300 ...
-
Tumour Extracellular Vesicles Induce Neutrophil Extracellular Traps To Promote Lymph Node MetastasisbioRxiv - Cancer Biology 2023Quote: ... anti-SOX-10-AF488 (NBP2-59621AF488; Novus Bio),anti-LYVE-1 (AF2125; R&D Systems), anti-Ly6G-FITC (11-9668-80 ...
-
bioRxiv - Developmental Biology 2023Quote: The following antibodies were used: goat anti-PROX1 (Cat#: AF2727, R&D Systems, 1:100), rat anti-Endomucin (Cat# ...
-
bioRxiv - Immunology 2023Quote: ... T cell were pre-incubated with 1 mg/ml pertussis toxin (3097; R&D Systems) in RPMI-10 medium for 3 h at 37°C ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10% fetal bovine serum (FBS) and 1 ng/mL IL3 (R&D Systems) where indicated ...
-
bioRxiv - Neuroscience 2023Quote: The primary antibodies used for immunostaining were goat anti-Pdgfrα (1:250, R&D Systems), rabbit anti-Pdgfrα (1:250 ...
-
bioRxiv - Cancer Biology 2023Quote: ... containing 1% penicillin– streptomycin together with 10 ng/ml rhSCF (#255-SC, R&D Systems), 10 ng/ml rhTPO (#288-TP ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng ml−1 basic fibroblast growth factor (FGF2; R&D Systems, 233-FB) for 16 d ...
-
bioRxiv - Genetics 2024Quote: ... the tubules were incubated with primary antibodies against cKit (1:1000 R&D systems AF1356), DNMT3a (1:1000 Imgenex IMG-268A ...
-
bioRxiv - Cell Biology 2024Quote: PAECs (3.000 cells/chamber) were seeded onto fibronectin-coated (10 μg.mL-1; R&D Systems) 4-chamber slides (Nunc) ...
-
bioRxiv - Neuroscience 2024Quote: ... and basic fibroblast growth factor (bFGF, 20 ng ml-1, R&D Systems, 233-FB) until day 24 ...
-
bioRxiv - Bioengineering 2023Quote: ... 1x Penn/Strep and 10 ng ml-1 FGF9 (R&D Systems, 273-F9-025). On day 9 (metanephric mesenchyme stage) ...
-
bioRxiv - Neuroscience 2023Quote: ... The following antibodies were used: mouse anti-IGFBP3 (R&D systems, MAB305-100, 1:200), rabbit anti-PAI1/SERPINE1 (Thermo Fisher ...
-
bioRxiv - Neuroscience 2023Quote: ... the nuclei were then stained with anti-SOX10 antibody (R&D Systems, AF2864, 1:250) + anti-Goat AF488 (Invitrogen ...
-
bioRxiv - Physiology 2023Quote: ... Further incubations with anti-VEGFR2 N-terminal antibody (rabbit, 1:100, R&D Systems, USA) and goat anti-rabbit IgG H+L Alexa Fluor 488 (1:1000 ...
-
bioRxiv - Neuroscience 2023Quote: ... mice were first injected with vehicle (saline) or devazepide (1 mg/kg, R&D Systems) i.p ...
-
bioRxiv - Physiology 2024Quote: ... The slides were then stained with anti-insulin (AlexaFluor 488, 1:50; R&D Systems), anti-B220 (AlexaFluor 594 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Secondary antibody was added for ULBP 1 and 2/5/6 only (R&D Systems). Cells were then washed and fixed in 4% paraformaldehyde ...
-
bioRxiv - Developmental Biology 2023Quote: ... The membrane was incubated with anti-Mouse SOST/Sclerostin (R&D System, AF1589, 1:500) antibody in Bullet Blocking One (Nacalai Tesque ...
-
bioRxiv - Immunology 2024Quote: ... directly conjugated anti-CD3 (AF594, Clone UCHT1, R&D Systems, Cat# FAB100T, diluted 1:50) and anti-CD4 (AF647 ...
-
bioRxiv - Microbiology 2024Quote: ... Primary antibody against advanced glycosylation end-product specific receptor (AGER, R&D Systems, 1:250), pro-surfactant protein C (pro-SFTPC ...
-
bioRxiv - Immunology 2024Quote: ... and 1 ng/mL murine TGF-β1 (Cat# 7666-MB R&D Systems Minneapolis, MN). Cells were incubated 37°C 5% CO2 for 96 h ...
-
bioRxiv - Bioengineering 2024Quote: ... specifically the Mouse CD31/PECAM-1 Affinity Purified Polyclonal Ab (#AF3628, R&D Systems Inc). The antibody was incubated overnight with the tissue sections at a concentration of 10 μg/mL at 4°C ...
-
Angiogenesis in the mature mouse cortex is governed in a region specific and Notch1 dependent mannerbioRxiv - Neuroscience 2024Quote: ... or sheep anti-CD93 (label endothelial tip cells, 1:500 dilution, R&D Systems, AF1696). After 3 washes ...
-
bioRxiv - Neuroscience 2024Quote: ... Retinal explants were treated with 240 ng·ml-1 SHH C24II (R&D Systems, 1845-SH) diluted in warm culture medium for 30 minutes before fixation with 4% (w/v ...
-
bioRxiv - Neuroscience 2024Quote: ... Cell cultures were immunolabelled with O4 antibody diluted 1:200 (R&D Systems, Oakville, ON) for one hour ...
-
bioRxiv - Cell Biology 2020Quote: ... followed by incubation with antibodies against Nestin (MAB2736, 1:50, R&D Systems, Cambridge, MA, USA) or Ki-67 (NB600-1252 ...
-
bioRxiv - Cancer Biology 2020Quote: ... TMAs processed from immunohistochemistry to visualize phosphorylated (p-) CD117 (R&D Systems, 1:50, RRID: AB_1152039) and prostate-specific membrane antigen (PSMA ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.01 μg ml −1 of granulocyte macrophage colony-stimulating factor (GM-CSF; R&D Systems). After 7 days ...
-
bioRxiv - Neuroscience 2022Quote: ... iTF-Microglia were stained with 1:200 anti-hCD38 PE (R&D Systems; Cat. No. FAB2404P).
-
bioRxiv - Bioengineering 2022Quote: ... The following primary antibodies were used in immunostaining: Anti-FOXA2 (R&D systems, #AF2400; 1:100), Anti-OLIG2 (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... and goat anti-platelet derived growth factor receptor-alpha (PDGFRα, R&D systems #AF1062, 1:200), in a PBS-based diluent buffer containing 10% normal donkey serum and 0.2% Triton-X100 ...
-
bioRxiv - Neuroscience 2021Quote: ... We used following primary antibodies and dilutions: anti-(murine)SorCS2 1:1000 (#AF4237, R&D Systems), anti-DARPP-32 1:1000 (#AB40801 ...
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Neuroscience 2019Quote: ... and BSA (2%) and stained with following primary antibodies: PI16 (1:75, R&D Systems AF4929), GLUT1 (1:250 ...
-
bioRxiv - Neuroscience 2019Quote: ... The following primary antibodies were used in the study: PI16 (1:750, R&D Systems AF4929), α-SMA (1:1500 ...
-
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian CancerbioRxiv - Cancer Biology 2020Quote: ... and resuspended in PBSA containing a ∼50 fold molar excess of PD-1 (R&D Systems) to render unbinding events irreversible ...